Live News Categoriesequity

Chong Kun Dang Holdings Corp. (001630.KS) News

Follow Chong Kun Dang Holdings Corp. (001630.KS) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol 001630.KS Asset equity Sector Markets 90 days 1 Last 37,350 Updated Sep 30, 2026, 06:36 AM UTC Open live news feed

M Kyungbo Pharma unit of Chongkundang gets court stay on approval cancellation pending appeal A court injunction suspends Kyungbo Pharmaceutical’s approval-cancellation effect until 30 days after the appellate ruling; affected sales exposure remains KRW 13.48 billion (5.65% of 2024 revenue), with suspension start EQUITY | Sep 30, 2026, 06:36 AM UTC